Terizidone

DB12954ApprovedInvestigationalWithdrawnSmall molecule

Terizidone has been used in trials studying the treatment of Tuberculosis, HIV Infections, Multidrug Resistant Tuberculosis, and Extensively-drug Resistant Tuberculosis.

Chemical structure of Terizidone
Formula / weight
C14H14N4O4 · 302.29 g/mol (avg)

Resolves to

Compound
UNII1199LEX5N8CAS25683-71-0ChEMBLCHEMBL2107553ChEBI135278PubChem65720
Clinical / RWD
RxNorm57047ATCJ04AK03
Structure
InChIKeyODKYYBOHSVLGNU-IAGONARPSA-NSMILESO=C1NOCC1\N=C\C1=CC=C(\C=N\C2CONC2=O)C=C1

What you can answer from here — as of March 06, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 4 drug categories
Sign in

Which companies are running trials of Terizidone, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In